Ganshina, Inna P.
| Issue | Section | Title | Abstract | File |
| Vol 22, No 2 (2020) | Best Practice | Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience | Abstract |
 (Rus) (Eng) |
| Vol 22, No 4 (2020) | CLINICAL ONCOLOGY | The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib | Abstract |
(Rus) |
| Vol 22, No 4 (2020) | CLINICAL ONCOLOGY | Novel therapeutic strategies for patients with metastatic triple-negative breast cancer | Abstract |
(Rus) |
| Vol 22, No 4 (2020) | CLINICAL ONCOLOGY | Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor | Abstract |
(Rus) |